Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02407002 · ClinicalTrials.gov registry record

Safety of Nitroglycerin for Field Treatment of STEMI

A clinical trial of Myocardial Infarction, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

Completed
Registry status
940
Enrollment target
3
Study locations

NCT02407002 is a study of Myocardial Infarction that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 940 participants, below the 4,667-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02407002, a study of Myocardial Infarction, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

COMPLETED
Registry status
940 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to quantify the risk of hypotension due to field treatment with nitroglycerin in patients with ST-elevation myocardial infarction, particularly right ventricular infarcts, and secondarily to evaluate the benefit to pain relief..

Conditions Studied

Myocardial Infarction

Study Locations (3)

California

  • Cedars Sinai Medical Center - Los Angeles
  • UCLA Ronald Reagan Medical Center - Los Angeles
  • Harbor-UCLA Medical Center - Torrance

Trial Details

FieldValue
Enrollment Target 940 participants
Start Date 2015-06
Est. Completion 2017-04-30

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

55 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02407002

The ClinicalTrials.gov registry entry for NCT02407002 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 940 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,667-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (80% lower). The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT02407002 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02407002 about?

NCT02407002 is a clinical study titled "Safety of Nitroglycerin for Field Treatment of STEMI". The purpose of this study is to quantify the risk of hypotension due to field treatment with nitroglycerin in patients with ST-elevation myocardial infarction, particularly right ventricular infarcts, and secondarily to evaluate the benefit to pain relief..

What is the current status of trial NCT02407002?

This trial is currently completed. The enrollment target is 940 participants. The study started on 2015-06. Estimated completion is 2017-04-30.

What conditions does trial NCT02407002 study?

This clinical trial studies the following conditions: Myocardial Infarction.

Who is sponsoring clinical trial NCT02407002?

This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02407002 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.